Quantum Biopharma Ltd.(QNTM)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated .

Quantum Biopharma Ltd. (QNTM) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. QNTM is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $0.3m in revenue and is scored on the micro-cap board instead. Top institutional holders of QNTM by reported 13-F value include AdvisorShares Investments, JANE STREET GROUP, Platform Technology Partners, based on the most recent SEC filings. QNTM trades on the Nasdaq exchange and files with the SEC under CIK 1771885. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate QNTM daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Quantum Biopharma Ltd. directly from SEC EDGAR.

QNTM key financials by period

Quantum Biopharma Ltd. reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodFormRevenueNet incomeOperating margin
FY 201940-F/A$257.1K——

Institutions holding QNTM

Institutional investors reporting a position in Quantum Biopharma Ltd. on SEC Form 13F.
InstitutionSharesValueReported
AdvisorShares Investments203,564$736.9K2026-06-30
JANE STREET GROUP48,355$175.0K2026-06-30
Platform Technology Partners41,116$148.8K2026-06-30
UBS Group AG33,405$120.9K2026-06-30
Steward Partners Investment Advisory27,881$100.9K2026-06-30
CITADEL ADVISORS15,863$57.4K2026-06-30
Marex Group plc13,436$48.6K2026-06-30
Mariner10,000$36.2K2026-06-30
NBC SECURITIES7,000$25.3K2026-06-30
OSAIC6,295$22.8K2026-06-30
SEC EDGAR: CIK 1771885 →
QNTM

Quantum Biopharma Ltd.

QNTM
NasdaqSmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

Below size threshold

Below the main board's size threshold of $25M annual revenue or $100M total assets. This company reported $0.3M in revenue and is scored on the micro-cap board instead.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Price Chart

Email me the moment this company reports earnings
AI Research Report
Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.
Upgrade to Pro
Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.
Reading the latest SEC filing… (first load can take ~20s)

Financial metrics will appear once SEC EDGAR data is ingested for this company.

Top Institutional Holders

as of Q2 2026
$1.50M total
AdvisorShares Investments LLC
$736.9K+336.7%
JANE STREET GROUP, LLC
$175.0K+53.5%
Platform Technology Partners
$148.8K0.0%
UBS Group AG
$120.9K+361.6%
Steward Partners Investment Advisory, LLC
$100.9K+536.4%
CITADEL ADVISORS LLC
$57.4K0.0%
Marex Group plc
$48.6K-0.2%
Mariner, LLC
$36.2K-0.6%
NBC SECURITIES, INC.
$25.3KNew
OSAIC HOLDINGS, INC.
$22.8K-1.3%
Loading ratio trend…